Raleigh Capital Management Inc. Makes New Investment in Healthpeak Properties, Inc. (NYSE:DOC)

Raleigh Capital Management Inc. acquired a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 9,777 shares of the real estate investment trust’s stock, valued at approximately $224,000.

Other large investors have also recently bought and sold shares of the company. Atomi Financial Group Inc. acquired a new position in Healthpeak Properties during the 3rd quarter worth $399,000. Pensionfund Sabic acquired a new position in Healthpeak Properties during the 3rd quarter worth $2,556,000. Mirador Capital Partners LP acquired a new position in Healthpeak Properties during the 3rd quarter worth $737,000. Sarasin & Partners LLP acquired a new position in Healthpeak Properties during the 3rd quarter worth $10,425,000. Finally, GAMMA Investing LLC acquired a new position in Healthpeak Properties during the 3rd quarter worth $605,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

Shares of NYSE DOC opened at $22.43 on Wednesday. The stock has a market capitalization of $15.79 billion, a price-to-earnings ratio of 64.09, a PEG ratio of 2.27 and a beta of 1.14. The business has a 50-day moving average of $22.19 and a 200-day moving average of $20.60. The company has a debt-to-equity ratio of 0.91, a current ratio of 0.70 and a quick ratio of 0.70. Healthpeak Properties, Inc. has a fifty-two week low of $15.24 and a fifty-two week high of $23.14.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Thursday, July 25th. The real estate investment trust reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.23). The company had revenue of $695.50 million during the quarter, compared to the consensus estimate of $665.11 million. Healthpeak Properties had a net margin of 11.93% and a return on equity of 3.51%. Healthpeak Properties’s revenue was up 27.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.45 EPS. As a group, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.8 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on DOC. Citigroup increased their price target on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Royal Bank of Canada increased their price target on Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, July 30th. Scotiabank increased their price target on Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a research note on Monday, September 9th. StockNews.com downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Saturday. Finally, Deutsche Bank Aktiengesellschaft raised Healthpeak Properties from a “hold” rating to a “buy” rating and increased their price target for the company from $20.00 to $28.00 in a research note on Monday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $22.62.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.